Kelly T. Smith

686 total citations
24 papers, 450 citations indexed

About

Kelly T. Smith is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Kelly T. Smith has authored 24 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 14 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Kelly T. Smith's work include Immunotherapy and Immune Responses (16 papers), Cancer Immunotherapy and Biomarkers (12 papers) and CAR-T cell therapy research (8 papers). Kelly T. Smith is often cited by papers focused on Immunotherapy and Immune Responses (16 papers), Cancer Immunotherapy and Biomarkers (12 papers) and CAR-T cell therapy research (8 papers). Kelly T. Smith collaborates with scholars based in United States, Qatar and France. Kelly T. Smith's co-authors include Craig L. Slingluff, Gina R. Petroni, Kimberly A. Chianese‐Bullock, Mark E. Smolkin, Walter C. Olson, Donna H. Deacon, Nolan A. Wages, Nikole Varhegyi, Elizabeth Gaughan and William W. Grosh and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Clinical Microbiology and The Journal of Urology.

In The Last Decade

Kelly T. Smith

21 papers receiving 446 citations

Peers

Countries citing papers authored by Kelly T. Smith

Since Specialization

Citations

This map shows the geographic impact of Kelly T. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly T. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly T. Smith more than expected).

Fields of papers citing papers by Kelly T. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly T. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly T. Smith. The network helps show where Kelly T. Smith may publish in the future.

Co-authorship network of co-authors of Kelly T. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly T. Smith. A scholar is included among the top collaborators of Kelly T. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly T. Smith. Kelly T. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	1466 Phase I/II clinical trial of a melanoma vaccine targeting shared nonmutated antigens and a shared mutated neoantigen with an agonistic CD40 antibody (CDX-1140) plus TLR agonist (polyICLC) 2024 ·(unknown), Gina R. Petroni, (unknown), Elizabeth Gaughan, (unknown), (unknown), Varinder Kaur, Kimberly A. Chianese‐Bullock, Kelly T. Smith, Paul Wright, Jennifer Bryant, Ileana S. Mauldin, Timothy N. J. Bullock, Craig L. Slingluff	1
2	Giant mediastinal bronchial artery aneurysm mimicking mediastinal mass: A case report and brief review of the literature 2022 ·SHILAP Revista de lepidopterología ·Aneri Balar, Dhairya A. Lakhani, (unknown), Kelly T. Smith, (unknown)	0
3	Distal cholangiocarcinoma: case report and brief review of the literature 2022 ·SHILAP Revista de lepidopterología ·Quincy A. Hathaway, Dhairya A. Lakhani, Aneri Balar, (unknown), Matthew Krafft, (unknown), Carl Schmidt, Kelly T. Smith, (unknown)	1
4	Phase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naïve and PD-1 antibody-experienced patients with melanoma (MEL64) 2022 ·Journal for ImmunoTherapy of Cancer ·(unknown), Gina R. Petroni, Ileana S. Mauldin, Kimberly A. Chianese‐Bullock, Walter C. Olson, Kelly T. Smith, Lynn T. Dengel, (unknown), William W. Grosh, Varinder Kaur, Nikole Varhegyi, Elizabeth Gaughan, Craig L. Slingluff	17
5	Granulomatosis with polyangiitis: A case report and brief review of literature 2021 ·SHILAP Revista de lepidopterología ·Dhairya A. Lakhani, Aneri Balar, (unknown), (unknown), (unknown), Kelly T. Smith, (unknown)	5
6	Congenital adrenal hyperplasia with associated giant adrenal myelolipoma, testicular adrenal rest tumors and primary pigmented nodular adrenocortical disease: A case report and brief review of the literature 2021 ·SHILAP Revista de lepidopterología ·Aaron Jacobson, (unknown), Alan Thomay, (unknown), (unknown), Dhairya A. Lakhani, Kelly T. Smith	1
7	388 A trial to evaluate the safety, immunogenicity, and clinical activity of a helper peptide vaccine plus PD-1 blockade (Mel64, PATHVACS: PD-1 antibody and T-helper vaccine and correlative studies) 2021 ·Regular and Young Investigator Award Abstracts ·Craig L. Slingluff, Kimberly A. Chianese‐Bullock, Ileana S. Mauldin, Walter C. Olson, Kelly T. Smith, Lynn T. Dengel, (unknown), Elizabeth Gaughan, Varinder Kaur, William W. Grosh	0
8	Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists with or without incomplete Freund’s adjuvant (IFA) for resected high-risk melanoma 2021 ·Journal for ImmunoTherapy of Cancer ·Sapna P. Patel, Gina R. Petroni, Jason Roszik, Walter C. Olson, Nolan A. Wages, Kimberly A. Chianese‐Bullock, Mark E. Smolkin, Nikole Varhegyi, Elizabeth Gaughan, Kelly T. Smith, (unknown), Emily H. Hall, Sacha Gnjatic, Patrick Hwu, Craig L. Slingluff	33
9	A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund’s adjuvant in melanoma patients 2019 ·Journal for ImmunoTherapy of Cancer ·Marit M. Melssen, Gina R. Petroni, Kimberly A. Chianese‐Bullock, Nolan A. Wages, William W. Grosh, Nikole Varhegyi, Mark E. Smolkin, Kelly T. Smith, (unknown), Donna H. Deacon, Elizabeth Gaughan, Craig L. Slingluff	74
10	A pilot study of the immunogenicity of a 9-peptide breast cancer vaccine plus poly-ICLC in early stage breast cancer 2017 ·Journal for ImmunoTherapy of Cancer ·Patrick M. Dillon, Gina R. Petroni, Mark E. Smolkin, David R. Brenin, Kimberly A. Chianese‐Bullock, Kelly T. Smith, Walter C. Olson, (unknown), (unknown), Christiana Brenin, Emily H. Hall, Craig L. Slingluff	50
11	Intratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastases 2016 ·Cancer Immunology Immunotherapy ·Ileana S. Mauldin, Nolan A. Wages, (unknown), Ena Wang, Mark E. Smolkin, Walter C. Olson, Donna H. Deacon, Kelly T. Smith, (unknown), Kimberly A. Chianese‐Bullock, Lynn T. Dengel, Francesco M. Marincola, Gina R. Petroni, David W. Mullins, Craig L. Slingluff	44
12	Topical treatment of melanoma metastases with imiquimod, plus administration of a cancer vaccine, promotes immune signatures in the metastases 2016 ·Cancer Immunology Immunotherapy ·Ileana S. Mauldin, Nolan A. Wages, (unknown), Ena Wang, Walter C. Olson, Donna H. Deacon, Kelly T. Smith, (unknown), Jessica E. Teague, Mark E. Smolkin, Kimberly A. Chianese‐Bullock, Rachael A. Clark, Gina R. Petroni, Francesco M. Marincola, David W. Mullins, Craig L. Slingluff	37
13	A randomized pilot trial testing the safety and immunologic effects of a MAGE-A3 protein plus AS15 immunostimulant administered into muscle or into dermal/subcutaneous sites 2015 ·Cancer Immunology Immunotherapy ·Craig L. Slingluff, Gina R. Petroni, Walter C. Olson, Mark E. Smolkin, Kimberly A. Chianese‐Bullock, Ileana S. Mauldin, Kelly T. Smith, Donna H. Deacon, Nikole Varhegyi, (unknown), (unknown), Kristy J. Scott, (unknown), William W. Grosh	28
14	Pilot clinical trials testing the safety and effects on the metastatic melanoma microenvironment of intratumoral interferon-gamma or imiquimod, plus a multipeptide melanoma vaccine 2015 ·Journal for ImmunoTherapy of Cancer ·Ileana S. Mauldin, Nolan A. Wages, (unknown), Ena Wang, Mark E. Smolkin, Walter C. Olson, Donna H. Deacon, Kelly T. Smith, (unknown), Jessica E. Teague, Rachael A. Clark, Francesco M. Marincola, Gina R. Petroni, David W. Mullins, Craig L. Slingluff	1
15	Immune correlates of varlilumab (CDX-1127) treated cancer patients are consistent with CD27 costimulatory activity 2014 ·Timothy N. J. Bullock, (unknown), (unknown), Kelly T. Smith, (unknown), Jeffrey R. Infante, (unknown), Stephen M. Ansell, Venky Ramakrishna, Laura Vitale, Thomas Hawthorne, (unknown), Michael Yellin, Thomas A. Davis, Tibor Keler	1
16	A case of spontaneous systemic immunity to melanoma associated with cure after amputation for extensive regional recurrence 2013 ·Cancer Immunology Immunotherapy ·(unknown), Louis B. Brill, Kelly T. Smith, Donna H. Deacon, James W. Patterson, William W. Grosh, Achim A. Jungbluth, Sacha Gnjatic, Craig L. Slingluff	1
17	Cytogenetics: Oncology Nurses in Advanced Practice Decipher del(13q14) and t(14:16) 2012 ·Clinical journal of oncology nursing ·Stephanie Jacobson, (unknown), Kelly T. Smith, (unknown)	1
18	Immunogenicity for CD8+ and CD4+ T Cells of 2 Formulations of an Incomplete Freund's Adjuvant for Multipeptide Melanoma Vaccines 2010 ·Journal of Immunotherapy ·Craig L. Slingluff, Gina R. Petroni, Mark E. Smolkin, Kimberly A. Chianese‐Bullock, Kelly T. Smith, Cheryl Murphy, (unknown), Patrice Y. Neese, William W. Grosh, (unknown), Merrick I. Ross, Margaret von Mehren, Naomi B. Haas, Marc Boisvert, John M. Kirkwood	24
19	101: Depression Mediates Poorer Quality of Life in Partners of Men with Chronic Prostatitis/Chronic Pelvic Pain Syndrome 2006 ·The Journal of Urology ·Dean A. Tripp, Joachim Nickel, (unknown), Kelly T. Smith, Caroline F. Pukall, (unknown)	1
20	Six-Year Molecular Analysis of Burkholderia cepacia Complex Isolates among Cystic Fibrosis Patients at a Referral Center for Lung Transplantation 2002 ·Journal of Clinical Microbiology ·David G. Heath, (unknown), (unknown), Kelly T. Smith, Jonathan C. Routh, John J. LiPuma, Robert M. Aris, David J. Weber, Peter H. Gilligan	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact